282 related articles for article (PubMed ID: 28740126)
1. Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer.
Korpal M; Puyang X; Jeremy Wu Z; Seiler R; Furman C; Oo HZ; Seiler M; Irwin S; Subramanian V; Julie Joshi J; Wang CK; Rimkunas V; Tortora D; Yang H; Kumar N; Kuznetsov G; Matijevic M; Chow J; Kumar P; Zou J; Feala J; Corson L; Henry R; Selvaraj A; Davis A; Bloudoff K; Douglas J; Kiss B; Roberts M; Fazli L; Black PC; Fekkes P; Smith PG; Warmuth M; Yu L; Hao MH; Larsen N; Daugaard M; Zhu P
Nat Commun; 2017 Jul; 8(1):103. PubMed ID: 28740126
[TBL] [Abstract][Full Text] [Related]
2. Recurrent activating mutations of PPARγ associated with luminal bladder tumors.
Rochel N; Krucker C; Coutos-Thévenot L; Osz J; Zhang R; Guyon E; Zita W; Vanthong S; Hernandez OA; Bourguet M; Badawy KA; Dufour F; Peluso-Iltis C; Heckler-Beji S; Dejaegere A; Kamoun A; de Reyniès A; Neuzillet Y; Rebouissou S; Béraud C; Lang H; Massfelder T; Allory Y; Cianférani S; Stote RH; Radvanyi F; Bernard-Pierrot I
Nat Commun; 2019 Jan; 10(1):253. PubMed ID: 30651555
[TBL] [Abstract][Full Text] [Related]
3. Re: Evasion of Immunosurveillance by Genomic Alterations of PPARγ/RXRα in Bladder Cancer.
Atala A
J Urol; 2018 May; 199(5):1115-1116. PubMed ID: 29677905
[No Abstract] [Full Text] [Related]
4. Heterodimer formation with retinoic acid receptor RXRα modulates coactivator recruitment by peroxisome proliferator-activated receptor PPARγ.
Kilu W; Merk D; Steinhilber D; Proschak E; Heering J
J Biol Chem; 2021 Jul; 297(1):100814. PubMed ID: 34081964
[TBL] [Abstract][Full Text] [Related]
5. Manipulation of reciprocal salt bridges at the heterodimerization interface alters the dimerization properties of mouse RXRalpha and PPARgamma1.
Chan LS; Wells RA
Biochem Biophys Res Commun; 2007 Jul; 358(4):1080-5. PubMed ID: 17521607
[TBL] [Abstract][Full Text] [Related]
6. Bladder cancer: PPARγ-RXRα alterations promote immune evasion.
Sidaway P
Nat Rev Urol; 2017 Sep; 14(9):515. PubMed ID: 28786421
[No Abstract] [Full Text] [Related]
7. Blockade of DC-SIGN
Hu B; Wang Z; Zeng H; Qi Y; Chen Y; Wang T; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Dai B; Guo J; Xu L; Zhang W; Xu J
Cancer Res; 2020 Apr; 80(8):1707-1719. PubMed ID: 32060149
[TBL] [Abstract][Full Text] [Related]
8. Molecular determinants of magnolol targeting both RXRα and PPARγ.
Zhang H; Xu X; Chen L; Chen J; Hu L; Jiang H; Shen X
PLoS One; 2011; 6(11):e28253. PubMed ID: 22140563
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the human endogenous retroviral Syncytin-1 and cell-cell fusion by the nuclear hormone receptors PPARγ/RXRα in placentogenesis.
Ruebner M; Langbein M; Strissel PL; Henke C; Schmidt D; Goecke TW; Faschingbauer F; Schild RL; Beckmann MW; Strick R
J Cell Biochem; 2012 Jul; 113(7):2383-96. PubMed ID: 22573555
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral TIGIT
Liu Z; Zhou Q; Wang Z; Zhang H; Zeng H; Huang Q; Chen Y; Jiang W; Lin Z; Qu Y; Xiong Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Xu L; Dai B; Guo J; Wang J; Chang Y; Zhang W
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32817209
[TBL] [Abstract][Full Text] [Related]
11. Poor clinical outcomes and immunoevasive contexture in interleukin-9 abundant muscle-invasive bladder cancer.
Zhou Q; Zhang H; Wang Z; Zeng H; Liu Z; Huang Q; Lin Z; Qu Y; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Dai B; Guo J; Zhu Y; Xu L; Xu J
Int J Cancer; 2020 Dec; 147(12):3539-3549. PubMed ID: 32734613
[TBL] [Abstract][Full Text] [Related]
12. Functional role of RXRs and PPARgamma in mature adipocytes.
Metzger D; Imai T; Jiang M; Takukawa R; Desvergne B; Wahli W; Chambon P
Prostaglandins Leukot Essent Fatty Acids; 2005 Jul; 73(1):51-8. PubMed ID: 15936932
[TBL] [Abstract][Full Text] [Related]
13. Atomic structure of mutant PPARgamma LBD complexed with 15d-PGJ2: novel modulation mechanism of PPARgamma/RXRalpha function by covalently bound ligands.
Waku T; Shiraki T; Oyama T; Morikawa K
FEBS Lett; 2009 Jan; 583(2):320-4. PubMed ID: 19101554
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex.
Lemkul JA; Lewis SN; Bassaganya-Riera J; Bevan DR
PLoS One; 2015; 10(5):e0123984. PubMed ID: 25954810
[TBL] [Abstract][Full Text] [Related]
15. Genomic Activation of
Goldstein JT; Berger AC; Shih J; Duke FF; Furst L; Kwiatkowski DJ; Cherniack AD; Meyerson M; Strathdee CA
Cancer Res; 2017 Dec; 77(24):6987-6998. PubMed ID: 28923856
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responses.
Zeng H; Liu Z; Wang Z; Zhou Q; Qi Y; Chen Y; Chen L; Zhang P; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Dai B; Guo J; Xu L; Zhang W; Xu J
Int J Cancer; 2020 Jan; 146(2):542-552. PubMed ID: 31584197
[TBL] [Abstract][Full Text] [Related]
17. [Effects of hexabromocyclododecanes on retinoid X receptor α, pregnane X receptor and peroxisome proliferator-activated receptor γ].
Wan K; Jiang Y; Zhang J; Wang X; Lei Y; Li Y; Xiao Y; Mei S; Zhou J
Wei Sheng Yan Jiu; 2017 May; 46(3):396-403. PubMed ID: 29903249
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometry-based FRET identifies binding intensities in PPARγ1 protein-protein interactions in living cells.
Trümper V; von Knethen A; Preuß A; Ermilov E; Hackbarth S; Kuchler L; Gunne S; Schäfer A; Bornhütter T; Vereb G; Ujlaky-Nagy L; Brüne B; Röder B; Schindler M; Parnham MJ; Knape T
Theranostics; 2019; 9(19):5444-5463. PubMed ID: 31534496
[TBL] [Abstract][Full Text] [Related]
19. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
Tsujie M; Nakamori S; Okami J; Hayashi N; Hiraoka N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
Exp Cell Res; 2003 Sep; 289(1):143-51. PubMed ID: 12941612
[TBL] [Abstract][Full Text] [Related]
20. Transactivation of the human retinoid X receptor by organotins: use of site-directed mutagenesis to identify critical amino acid residues for organotin-induced transactivation.
Hiromori Y; Aoki A; Nishikawa J; Nagase H; Nakanishi T
Metallomics; 2015 Jul; 7(7):1180-8. PubMed ID: 25985376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]